PreveCeutical Medical Inc.
PREV
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.50% | -37.77% | -54.14% | 38.04% | -226.42% |
| Total Depreciation and Amortization | 0.00% | 5.56% | 0.00% | 5.56% | -62.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.57% | 4.08% | -8.96% | -47.54% | 148.19% |
| Change in Net Operating Assets | -91.32% | 24.03% | 229.15% | -27.53% | 87.16% |
| Cash from Operations | -72.53% | -126.87% | -61.41% | 38.67% | -116.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -104.17% | 75.00% | -- |
| Total Debt Issued | 123.66% | -53.09% | 44.44% | -39.54% | -61.29% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 228.57% | 126.52% | 72.51% | -39.30% | -61.44% |
| Foreign Exchange rate Adjustments | 50.00% | 114.29% | -250.00% | 120.00% | 99.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21,150.00% | 100.00% | 29.63% | 233.33% | -108.70% |